These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 24844163

  • 21. Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery.
    Fan W, Xia D, Zhu Q, Li X, He S, Zhu C, Guo S, Hovgaard L, Yang M, Gan Y.
    Biomaterials; 2018 Jan; 151():13-23. PubMed ID: 29055774
    [Abstract] [Full Text] [Related]

  • 22. Modified nanoparticles with cell-penetrating peptide and amphipathic chitosan derivative for enhanced oral colon absorption of insulin: preparation and evaluation.
    Guo F, Zhang M, Gao Y, Zhu S, Chen S, Liu W, Zhong H, Liu J.
    Drug Deliv; 2016 Jul; 23(6):2003-14. PubMed ID: 26181840
    [Abstract] [Full Text] [Related]

  • 23. Microfluidic Assembly of a Multifunctional Tailorable Composite System Designed for Site Specific Combined Oral Delivery of Peptide Drugs.
    Araújo F, Shrestha N, Shahbazi MA, Liu D, Herranz-Blanco B, Mäkilä EM, Salonen JJ, Hirvonen JT, Granja PL, Sarmento B, Santos HA.
    ACS Nano; 2015 Aug 25; 9(8):8291-302. PubMed ID: 26235314
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Protein delivery based on uncoated and chitosan-coated mesoporous silicon microparticles.
    Pastor E, Matveeva E, Valle-Gallego A, Goycoolea FM, Garcia-Fuentes M.
    Colloids Surf B Biointerfaces; 2011 Dec 01; 88(2):601-9. PubMed ID: 21855304
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Enhanced in vitro permeation of furosemide loaded into thermally carbonized mesoporous silicon (TCPSi) microparticles.
    Kaukonen AM, Laitinen L, Salonen J, Tuura J, Heikkilä T, Limnell T, Hirvonen J, Lehto VP.
    Eur J Pharm Biopharm; 2007 Jun 01; 66(3):348-56. PubMed ID: 17240128
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Bioinspired zwitterionic polyphosphoester modified porous silicon nanoparticles for efficient oral insulin delivery.
    Rao R, Liu X, Li Y, Tan X, Zhou H, Bai X, Yang X, Liu W.
    Biomater Sci; 2021 Feb 09; 9(3):685-699. PubMed ID: 33330897
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Controlled Dissolution of Griseofulvin Solid Dispersions from Electrosprayed Enteric Polymer Micromatrix Particles: Physicochemical Characterization and in Vitro Evaluation.
    Roine J, Kaasalainen M, Peurla M, Correia A, Araújo F, Santos HA, Murtomaa M, Salonen J.
    Mol Pharm; 2015 Jul 06; 12(7):2254-64. PubMed ID: 26035734
    [Abstract] [Full Text] [Related]

  • 37. Mutlifunctional nanoparticles prepared from arginine-modified chitosan and thiolated fucoidan for oral delivery of hydrophobic and hydrophilic drugs.
    Chen CH, Lin YS, Wu SJ, Mi FL.
    Carbohydr Polym; 2018 Aug 01; 193():163-172. PubMed ID: 29773368
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.